APA (7th ed.) Citation

A, D., M, H., A, B., J, O., DM, L., L, M., . . . LM, W. (2024). Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Foundation. Clinical cancer research : an official journal of the American Association for Cancer Research, 30(23), 5314. https://doi.org/10.1158/1078-0432.CCR-24-1339

Chicago Style (17th ed.) Citation

A, Dhir, et al. "Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Foundation." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 30, no. 23 (2024): 5314. https://doi.org/10.1158/1078-0432.CCR-24-1339.

MLA (9th ed.) Citation

A, Dhir, et al. "Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Foundation." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 30, no. 23, 2024, p. 5314, https://doi.org/10.1158/1078-0432.CCR-24-1339.